Brief: Palvella Therapeutics Appoints Matthew Korenberg As Chief Financial Officer
Oct 17 (Reuters) - Ligand Pharmaceuticals Inc LGND.O :
* PALVELLA THERAPEUTICS APPOINTS MATTHEW E. KORENBERG AS
CHIEF
FINANCIAL OFFICER
Source text for Eikon: ID:nGNX2jGCc3
Further company coverage: LGND.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ligand Pharmaceuticals Incorporated
See all newsBrief: Ligand Acquires Royalty And Milestone Interest In Santen’s Ryjunea From Sydnexis For $23 Million
Ligand Pharmaceuticals Incorporated reports results for the quarter ended June 30 - Earnings Summary
Ligand Pharmaceuticals Q2 revenue rises on royalty growth
Brief: Ligand Pharmaceuticals Q2 EPS USD 2.22
U.S. RESEARCH ROUNDUP-Equinix, Goldman Sachs, JPMorgan